Literature DB >> 33853833

Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer.

Anthony M Musolf1, Claire L Simpson1,2, Bilal A Moiz1, Claudio W Pikielny3, Candace D Middlebrooks1, Diptasri Mandal4, Mariza de Andrade5, Michael D Cole3, Colette Gaba6, Ping Yang7, Ming You8, Yafang Li9, Elena Y Kupert8, Marshall W Anderson8, Ann G Schwartz10, Susan M Pinney11, Christopher I Amos9, Joan E Bailey-Wilson12.   

Abstract

Although lung cancer is known to be caused by environmental factors, it has also been shown to have genetic components, and the genetic etiology of lung cancer remains understudied. We previously identified a lung cancer risk locus on 6q23-25 using microsatellite data in families with a history of lung cancer. To further elucidate that signal, we performed targeted sequencing on nine of our most strongly linked families. Two-point linkage analysis of the sequencing data revealed that the signal was heterogeneous and that different families likely had different risk variants. Three specific haplotypes were shared by some of the families: 6q25.3-26 in families 42 and 44, 6q25.2-25.3 in families 47 and 59, and 6q24.2-25.1 in families 30, 33, and 35. Region-based logarithm of the odds scores and expression data identified the likely candidate genes for each haplotype overlap: ARID1B at 6q25.3, MAP3K4 at 6q26, and UTRN (6q24.1) and PHACTR2 (6q24.2). Further annotation was used to zero in on potential risk variants in those genes. All four genes are good candidate genes for lung cancer risk, having been linked to either lung cancer specifically or other cancers. However, this is the first time any of these genes has been implicated in germline risk. Functional analysis of these four genes is planned for future work. SIGNIFICANCE: This study identifies four genes associated with lung cancer risk, which could help guide future lung cancer prevention and treatment approaches. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33853833      PMCID: PMC8409178          DOI: 10.1158/0008-5472.CAN-20-3196

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  48 in total

1.  Familial aggregation of lung cancer among hospital patients.

Authors:  G K TOKUHATA; A M LILIENFELD
Journal:  Public Health Rep       Date:  1963-04       Impact factor: 2.792

2.  A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers.

Authors:  Christopher I Amos; Susan M Pinney; Yafang Li; Elena Kupert; Juwon Lee; Mariza A de Andrade; Ping Yang; Ann G Schwartz; Pam R Fain; Adi Gazdar; John Minna; Jonathan S Wiest; Dong Zeng; Henry Rothschild; Diptasri Mandal; Ming You; Teresa Coons; Colette Gaba; Joan E Bailey-Wilson; Marshall W Anderson
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

3.  Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

Authors:  A Barghorn; E J Speel; B Farspour; P Saremaslani; S Schmid; A Perren; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 4.  Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review.

Authors:  Paul Mitchell; Tony Mok; Helen Barraclough; Alena Strizek; Rebecca Lew; Maximiliano van Kooten
Journal:  Clin Lung Cancer       Date:  2011-12-06       Impact factor: 4.785

5.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Authors:  Rayjean J Hung; James D McKay; Valerie Gaborieau; Paolo Boffetta; Mia Hashibe; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Chu Chen; Gary Goodman; John K Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; John McLaughlin; Geoffrey Liu; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Jakob Linseisen; Françoise Clavel-Chapelon; Paolo Vineis; H Bas Bueno-de-Mesquita; Eiliv Lund; Carmen Martinez; Sheila Bingham; Torgny Rasmuson; Pierre Hainaut; Elio Riboli; Wolfgang Ahrens; Simone Benhamou; Pagona Lagiou; Dimitrios Trichopoulos; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Gary Macfarlane; Renato Talamini; Lorenzo Simonato; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  Inhibition of Human Glioma Cell Proliferation Caused by Knockdown of Utrophin Using a Lentivirus-Mediated System.

Authors:  Shang-Hang Shen; Ning Yu; Hao Xu; Xi-Yao Liu; Guo-Wei Tan; Zhan-Xiang Wang
Journal:  Cancer Biother Radiopharm       Date:  2016-05       Impact factor: 3.099

7.  Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Authors:  Bradley N Bidwell; Clare Y Slaney; Nimali P Withana; Sam Forster; Yuan Cao; Sherene Loi; Daniel Andrews; Thomas Mikeska; Niamh E Mangan; Shamith A Samarajiwa; Nicole A de Weerd; Jodee Gould; Pedram Argani; Andreas Möller; Mark J Smyth; Robin L Anderson; Paul J Hertzog; Belinda S Parker
Journal:  Nat Med       Date:  2012-07-22       Impact factor: 53.440

8.  The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer.

Authors:  Wenhui Chu; Xi Zhang; Lihua Qi; Yenan Fu; Peng Wang; Wei Zhao; Juan Du; Jing Zhang; Jun Zhan; Yunling Wang; Wei-Guo Zhu; Yu Yu; Hongquan Zhang
Journal:  Cancer Res       Date:  2020-04-20       Impact factor: 12.701

9.  Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells.

Authors:  Seiichiro Ishihara; Motoaki Yasuda; Akihiro Ishizu; Masayori Ishikawa; Hiroki Shirato; Hisashi Haga
Journal:  Oncotarget       Date:  2015-03-10

10.  Integrated analysis of germline and somatic variants in ovarian cancer.

Authors:  Krishna L Kanchi; Kimberly J Johnson; Charles Lu; Michael D McLellan; Mark D M Leiserson; Michael C Wendl; Qunyuan Zhang; Daniel C Koboldt; Mingchao Xie; Cyriac Kandoth; Joshua F McMichael; Matthew A Wyczalkowski; David E Larson; Heather K Schmidt; Christopher A Miller; Robert S Fulton; Paul T Spellman; Elaine R Mardis; Todd E Druley; Timothy A Graubert; Paul J Goodfellow; Benjamin J Raphael; Richard K Wilson; Li Ding
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more
  1 in total

1.  Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer.

Authors:  Wei Tan; Shiyi Liu; Zhimin Deng; Fangfang Dai; Mengqin Yuan; Wei Hu; Bingshu Li; Yanxiang Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-01       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.